Top compounds associated with response to LRRC37B


Feature Type Standardized
Nominal ANOVA
mRNA PX-12 CTRPv2 pan-cancer AAC 0.23 3e-15
mRNA barasertib CTRPv2 pan-cancer AAC 0.26 9e-15
mRNA nelarabine CTRPv2 pan-cancer AAC 0.3 5e-14
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.27 3e-13
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 3e-12
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.21 6e-12
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.24 6e-11
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.24 3e-10
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.21 7e-10
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 1e-09
Download CSV